UNITY BIOTECHNOLOGY INC - COM (UBX)

CUSIP: 91381U101

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class
Equity / COM
Total 13F shares
24,920,882
Share change
+3,023,897
Total reported value
$216,313,460
Price per share
$8.68
Number of holders
81
Value change
+$26,734,883
Number of buys
48
Number of sells
24

Quarterly Holders Quick Answers

What is CUSIP 91381U101?
CUSIP 91381U101 identifies UBX - UNITY BIOTECHNOLOGY INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of UNITY BIOTECHNOLOGY INC - COM (UBX) as of Q2 2020

As of 30 Jun 2020, UNITY BIOTECHNOLOGY INC - COM (UBX) was held by 81 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 24,920,882 shares. The largest 10 holders included FMR LLC, BAILLIE GIFFORD & CO, BlackRock Inc., Invus Financial Advisors, LLC, Capital World Investors, Mayo Clinic, VANGUARD GROUP INC, STATE STREET CORP, MILLENNIUM MANAGEMENT LLC, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 81 institutional shareholders reporting positions in this security for the Q2 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.